Close
Close
Treatment Database

The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.

You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.

Become a Partner.

Product Indication Date Designated
parsaclisib Mantle cell lymphoma Jun 12, 2019
Fully human immunoglobulin G1 monoclonal antibody that targets CD32b Mantle cell lymphoma Jan 29, 2019
Venetoclax Mantle cell lymphoma Dec 12, 2017
Venetoclax Mantle cell lymphoma Aug 31, 2017
Humanized monoclonal immunoglobulin G1 antibody directed against human CD19 conjugated to SG3199 through a protease cleavable valine-alanine linker Mantle cell lymphoma Jun 08, 2017
7-benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one-2HCL Mantle cell lymphoma (MCL) Feb 07, 2017
zanubrutinib Mantle cell lymphoma Jun 23, 2016
(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydroprazolo[1,5-a]pyrimidine-3-carboxamide Mantle cell lymphoma Jun 23, 2016
autologous T-cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor Mantle cell lymphoma Apr 28, 2016
Acalabrutinib Mantle cell lymphoma Mar 21, 2016
Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor Mantle cell lymphoma Oct 09, 2015
acalabrutinib Mantle cell lymphoma Sep 21, 2015
daratumumab Mantle cell lymphoma Aug 20, 2015
triterpenoid saponin Mantle cell lymphoma Jul 23, 2014
1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one Mantle cell lymphoma Mar 12, 2013
ibrutinib Mantle cell lymphoma Dec 03, 2012
ibrutinib Mantle cell lymphoma Dec 03, 2012
DNA plasmid vector expressing eIF5Ak50R protein, siRNA directed against the native eIF5A mRNA, and PEI (polyethyleneimine) Mantle cell lymphoma Jul 24, 2012
bortezomib Mantle cell lymphoma May 30, 2012
Lenalidomide Mantle cell lymphoma Oct 27, 2011